Raphael E. Pollock

27.8k total citations · 6 hit papers
369 papers, 18.7k citations indexed

About

Raphael E. Pollock is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Raphael E. Pollock has authored 369 papers receiving a total of 18.7k indexed citations (citations by other indexed papers that have themselves been cited), including 229 papers in Pulmonary and Respiratory Medicine, 160 papers in Oncology and 65 papers in Molecular Biology. Recurrent topics in Raphael E. Pollock's work include Sarcoma Diagnosis and Treatment (215 papers), Vascular Tumors and Angiosarcomas (90 papers) and Cardiac tumors and thrombi (64 papers). Raphael E. Pollock is often cited by papers focused on Sarcoma Diagnosis and Treatment (215 papers), Vascular Tumors and Angiosarcomas (90 papers) and Cardiac tumors and thrombi (64 papers). Raphael E. Pollock collaborates with scholars based in United States, Israel and China. Raphael E. Pollock's co-authors include Peter W. T. Pisters, Dina Lev, Alexander J. Lazar, Janice N. Cormier, Robert S. Benjamin, Kelly K. Hunt, Shreyaskumar Patel, Barry W. Feig, Gunar K. Zagars and Matthew T. Ballo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Raphael E. Pollock

356 papers receiving 18.3k citations

Hit Papers

Recurrence and Outcomes Following Hepatic Resection, Radi... 2003 2026 2010 2018 2004 2004 2003 2012 2016 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raphael E. Pollock United States 74 11.3k 7.9k 3.9k 3.8k 3.8k 369 18.7k
Masazumi Tsuneyoshi Japan 74 8.3k 0.7× 7.6k 1.0× 3.5k 0.9× 1.3k 0.4× 6.0k 1.6× 577 22.3k
Mark Krailo United States 76 6.8k 0.6× 5.7k 0.7× 1.7k 0.4× 1.5k 0.4× 4.1k 1.1× 392 18.7k
Eli Glatstein United States 79 10.8k 1.0× 7.3k 0.9× 1.8k 0.5× 1.6k 0.4× 3.8k 1.0× 357 20.4k
Rosalba Miceli Italy 55 5.4k 0.5× 4.5k 0.6× 1.5k 0.4× 1.7k 0.4× 2.6k 0.7× 251 10.6k
Pancras C.W. Hogendoorn Netherlands 85 15.7k 1.4× 6.9k 0.9× 9.5k 2.5× 2.0k 0.5× 4.0k 1.1× 443 26.7k
Michael P. LaQuaglia United States 61 5.4k 0.5× 3.4k 0.4× 1.7k 0.4× 1.0k 0.3× 3.4k 0.9× 325 13.3k
Peter Reichardt Germany 61 9.7k 0.9× 4.2k 0.5× 2.1k 0.5× 1.2k 0.3× 4.2k 1.1× 354 15.6k
Paul A. Meyers United States 66 9.0k 0.8× 4.2k 0.5× 3.3k 0.8× 2.1k 0.5× 2.3k 0.6× 262 15.7k
Piero Picci Italy 84 16.8k 1.5× 6.8k 0.9× 9.6k 2.5× 2.9k 0.8× 4.0k 1.1× 562 25.4k
Andrea Ferrari Italy 61 7.2k 0.6× 4.7k 0.6× 2.5k 0.7× 1.5k 0.4× 3.6k 1.0× 486 14.3k

Countries citing papers authored by Raphael E. Pollock

Since Specialization
Citations

This map shows the geographic impact of Raphael E. Pollock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael E. Pollock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael E. Pollock more than expected).

Fields of papers citing papers by Raphael E. Pollock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael E. Pollock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael E. Pollock. The network helps show where Raphael E. Pollock may publish in the future.

Co-authorship network of co-authors of Raphael E. Pollock

This figure shows the co-authorship network connecting the top 25 collaborators of Raphael E. Pollock. A scholar is included among the top collaborators of Raphael E. Pollock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphael E. Pollock. Raphael E. Pollock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dorayappan, Kalpana Deepa Priya, Dongju Park, Takahiko Sakaue, et al.. (2024). ISG15 mediates the function of extracellular vesicles in promoting ovarian cancer progression and metastasis. SHILAP Revista de lepidopterología. 3(2). e92–e92. 3 indexed citations
2.
Pollock, Raphael E., et al.. (2022). Cancer-Derived Extracellular Vesicles: Their Role in Sarcoma. Life. 12(4). 481–481. 3 indexed citations
3.
Konieczkowski, David J., Chengli Shen, Diamantis I. Tsilimigras, et al.. (2022). Prognostic factors in patients receiving surgery and radiation therapy for retroperitoneal sarcoma: A machine-learning analysis. Surgery. 173(3). 640–644. 4 indexed citations
4.
Wang, Yu, Diamantis I. Tsilimigras, Valerie P. Grignol, et al.. (2022). The Role of AKT in Soft Tissue Sarcoma: Review and Insights. Molecular Cancer Research. 20(10). 1471–1480. 2 indexed citations
5.
Casadei, Lucia, Federica Calore, Danielle Braggio, et al.. (2019). MDM2 Derived from Dedifferentiated Liposarcoma Extracellular Vesicles Induces MMP2 Production from Preadipocytes. Cancer Research. 79(19). 4911–4922. 26 indexed citations
6.
Subbiah, Vivek, Salah-Eddine Lamhamedi-Cherradi, Branko Cuglievan, et al.. (2018). Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival. Clinical Cancer Research. 24(19). 4865–4873. 61 indexed citations
7.
Casadei, Lucia, Federica Calore, Chad J. Creighton, et al.. (2017). Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma Progression. Cancer Research. 77(14). 3846–3856. 149 indexed citations
8.
Braggio, Danielle, Amanda E. Toland, Raphael E. Pollock, et al.. (2016). TGF-β and CTGF are Mitogenic Output Mediators of Wnt/β-Catenin Signaling in Desmoid Fibromatosis. Applied immunohistochemistry & molecular morphology. 25(8). 559–565. 12 indexed citations
9.
Bill, Kate Lynn J., Jeannine Garnett, Isabelle Meaux, et al.. (2015). SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma. Clinical Cancer Research. 22(5). 1150–1160. 86 indexed citations
10.
Lopez, Gonzalo, Chad J. Creighton, Hemant K. Bid, et al.. (2015). HDAC Inhibition for the Treatment of Epithelioid Sarcoma: Novel Cross Talk Between Epigenetic Components. Molecular Cancer Research. 14(1). 35–43. 17 indexed citations
11.
Garvey, Patrick B., et al.. (2013). Complex Reconstruction of Desmoid Tumor Resections Does Not Increase Desmoid Tumor Recurrence. Journal of the American College of Surgeons. 217(3). 472–480. 14 indexed citations
12.
Zhang, Pingyu, Katelynn Bill, Juehui Liu, et al.. (2012). MiR-155 Is a Liposarcoma Oncogene That Targets Casein Kinase-1α and Enhances β-Catenin Signaling. Cancer Research. 72(7). 1751–1762. 100 indexed citations
13.
Ghadimi, Markus P., Eric D. Young, Roman Belousov, et al.. (2012). Survivin Is a Viable Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors. Clinical Cancer Research. 18(9). 2545–2557. 36 indexed citations
14.
Savannah, Kari J. Brewer, Elizabeth G. Demicco, Kristelle Lusby, et al.. (2012). Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma. Clinical Cancer Research. 18(17). 4633–4645. 40 indexed citations
15.
Zimmerman, Mary Ann, Nur-Taz Rahman, Dafeng Yang, et al.. (2012). Unphosphorylated STAT1 Promotes Sarcoma Development through Repressing Expression of Fas and Bad and Conferring Apoptotic Resistance. Cancer Research. 72(18). 4724–4732. 38 indexed citations
16.
Ghadimi, Markus P., Gonzalo Lopez, Keila E. Torres, et al.. (2012). Targeting the PI3K/mTOR Axis, Alone and in Combination with Autophagy Blockade, for the Treatment of Malignant Peripheral Nerve Sheath Tumors. Molecular Cancer Therapeutics. 11(8). 1758–1769. 42 indexed citations
17.
Lahat, Guy, Alexander J. Lazar, Xuemei Wang, et al.. (2009). Increased Vascular Endothelial Growth Factor-C Expression Is Insufficient to Induce Lymphatic Metastasis in Human Soft-Tissue Sarcomas. Clinical Cancer Research. 15(8). 2637–2646. 11 indexed citations
18.
Ren, Wenhong, Borys Korchin, Quansheng Zhu, et al.. (2008). Epidermal Growth Factor Receptor Blockade in Combination with Conventional Chemotherapy Inhibits Soft Tissue Sarcoma Cell Growth In vitro and In vivo. Clinical Cancer Research. 14(9). 2785–2795. 33 indexed citations
19.
Lahat, Guy, Daniel Tuvin, C. Wei, et al.. (2008). New Perspectives for Staging and Prognosis in Soft Tissue Sarcoma. Annals of Surgical Oncology. 15(10). 2739–2748. 110 indexed citations
20.
Lev, Dina, Caimiao Wei, Matthew T. Ballo, et al.. (2007). Optimizing Treatment of Desmoid Tumors. Journal of Clinical Oncology. 25(13). 1785–1791. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026